Company News, Patents

Sytheon Seeks Exclusive Partner to Bring New Eczema Product to OTC Market

ActSES, which treats atopic dermatitis, has received further patent protection.

Sytheon has receive further patent protection for its new turnkey product which treats atopic dermatitis, and its looking for an exclusive partner to help bring it to the OTC dermatological market.   According to the company, there is currently an unmet need for a sustainable, safe and cost-effective product for those with mild to moderate Atopic Dermatitis (AD) or eczema. Sytheon has a turnkey product, ActSES, with solid science, patent protection and clinical validation by UC-Davis, CA...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters